[VSsupport]

<img alt="" height="1" width="1" />ARIAD restructures Merck partnership. SenoRx acquired by CR Bard. After the ...BioMedReports (subscription)LX1031 is the first TPH inhibitor to be evaluated in human clinical trials for the treatment of IBS. Results from the randomized, placebo-controlled study ...<nobr>and more »</nobr>

View the full article